An Expert View on the importance of embedding a modern quality culture from David Fryrear, executive vice president and head of quality assurance, Medical and Development, Astellas Pharma Global Development.
As life science organizations transform to keep pace with the speed of innovation, so too is our understanding of the value that quality assurance (QA) can deliver in supporting and advancing the treatments of the future.
Integrating and elevating quality practices across the entire therapy lifecycle is critical to our ongoing quest to modernize and become more agile. To realize the full potential of tomorrow’s innovation, quality cannot be considered the responsibility of just one function, team or individual. It is a capability, mindset and cultural norm that must be championed across organizations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze